Titles and Roles
- Professor, Department of Hematology and Medical Oncology
- Emory University School of Medicine
Board certified in hematology, medical oncology and internal medicine, Leonard T. Heffner Jr., MD, treats patients with hematological malignancies including leukemia, lymphomas, multiple myeloma and Waldenström's macroglobulinemia. Dr. Heffner began practicing at Emory in 1974.
Dr. Heffner holds memberships with American Medical Association, American Society of Blood and Marrow Transplantation, American Society of Clinical Oncology, American Society of Hematology, Eastern Cooperative Oncology Group, Georgia Society of Clinical Oncology, Medical Association of Atlanta and Medical Association of Georgia.
Dr. Heffner obtained his medical degree from Wake Forest University and completed specialty training in internal medicine at Emory University and Baylor College of Medicine. He did his subspecialty training in hematology and medical oncology at University of Miami and Emory University after which he was invited to join the faculty at Emory University.
Over the past 30 years, Leonard T. Heffner Jr., MD, has been active in clinical research in hematologic malignancies based on drug development protocols and cooperative group phase 2 and 3 protocols through the Southeastern Cancer Study Group and the Eastern Cooperative Oncology Group where he has been an active member of the Myeloma Committee. In the past few years this clinical research interest has extended to phase 1 trials, many as first-in-human type.
With his extensive clinical background, Dr. Heffner has helped to begin the clinical multiple myeloma program that has developed nationally along with the efforts of clinical colleagues. Currently, he has a goal of developing a similar regional and national program for Waldenström's macroglobulinemia and has just written a national ECOG-led intergroup protocol for macroglobulinemia and also is local principal investigator for several myeloma, lymphoma, acute lymphoblastic leukemia and chronic lymphocytic leukemia studies.